Anthropic’s $83 IPO and its lock-up calendar

Alex O'Donnell
Published
November 20, 2026
Last updated
November 20, 2026
Alex O'Donnell

Artificial Intelligence

November 20, 2026

Published
November 20, 2026
Last updated
November 20, 2026

Anthropic priced its IPO at $83 a share on Wednesday night, above the range it had marketed. Its stock began trading on Thursday, but early holders can’t sell most of their shares yet. The final prospectus sets the lock-up schedule, starting with a small allowance for employees and wider windows from Dec. 15. Elsewhere, Palo Alto Networks agreed to buy Applied Compute for $4.5 billion in stock, and Iceye offered cash for Italian rocket maker Avio. More on each below.

Anthropic priced its IPO at $83 and sold 980 million shares

Anthropic’s shares closed at $97.17 on Thursday, their first day of trading, 17.1% above the $83 IPO price, CNBC reported. They had opened at $111.50, Yahoo Finance reported. The $83 price, set Wednesday night, was above the $70 to $78 range the company had marketed, according to its final prospectus. The deal also grew, to 980 million shares from the 825 million in its Nov. 17 amended filing, raising $81.34 billion before fees.

The offering is the largest IPO on record, ahead of the roughly $75 billion SpaceX raised in June before its underwriters’ option, according to CNBC and Reuters. It came together after a rough stretch for tech stocks. The range was set on Nov. 10, after the Nasdaq had entered a correction, and it came in below earlier valuation expectations, as Tuesday’s Pulse noted, citing Reuters.

Most early shareholders, though, will have to wait weeks or longer to sell more than a fraction of their stock. The lock-up releases their shares in stages, according to the prospectus. Directors, officers and current and former employees can sell up to 10% of their locked-up shares from the first trading day. Certain other holders get release windows on Dec. 15 and Jan. 5, and some large pre-IPO holders wait up to a year for the bulk of their shares. Each date adds to the shares that can trade, which makes the calendar one thing holders and traders will be watching.

The company is also selling stock at $83 outside the offering. Seven companies, including Nvidia, Microsoft and Google, are buying $26.0 billion of non-voting Class N shares at the same price in a concurrent private placement, the prospectus says. Those buyers aren’t covered by the underwriters’ lock-up, though their shares are restricted securities subject to applicable holding periods and resell limitations.

Anthropic’s valuation changes depending on which shares are counted. At $83, the roughly 13.2 billion shares outstanding after the offering and the private placement, according to the prospectus, come to about $1.1 trillion. A fully diluted count also includes stock options and restricted stock. On that basis, Reuters put Anthropic at about $1.4 trillion at the top of the range on Nov. 10. Scaled to $83, the same count comes to about $1.5 trillion, the valuation AP reported after pricing.

For anyone holding Anthropic stock from before the IPO, the details depend on the group. The employee allowance also covers non-founder directors, officers and consultants. Certain holders of more than 0.5% get smaller early releases before the rest of their shares come free. The Pulse described that staged structure on Oct. 29, and the final prospectus now puts dates on it. Investors in Augment Collectives generally hold fund interests, not Anthropic shares directly.

Reported private-company financials and secondary-market indications may be unaudited, incomplete, non-standard, or based on limited transaction activity. They should not be relied upon as fair value, executable pricing, or a basis for any investment decision.

Augment and/or its affiliates hold a position in Anthropic.

Browse private-company pages on Augment for company information, recent coverage, and available market data.

Palo Alto Networks agreed to buy Applied Compute for $4.5 billion in stock

Fifteen days after Applied Compute raised at a $3.25 billion valuation, Palo Alto Networks agreed to buy it for $4.5 billion in stock. The startup helps businesses train and run their own AI models. Palo Alto announced the deal Wednesday and said the price is subject to adjustments. The deal needs regulatory clearance and is expected to close in Palo Alto’s fiscal third quarter of 2027.

Elad Gil led the earlier round, announced Nov. 3, and Nvidia participated, SiliconANGLE reported. The deal value is about 38% above that round’s valuation. (These comparisons involve securities that may have different rights, preferences, restrictions and economic characteristics and do not represent actual investor returns.)

The two numbers come from different processes. A round prices a slice of a company in a negotiation with new investors. An acquisition prices all of it, and this one still depends on adjustments and clearance.

For investors who joined that round, and for earlier holders, the payoff if the deal closes is Palo Alto stock rather than cash. What they receive depends on the merger terms. After closing, the value of their holding would move with Palo Alto’s share price instead of a private mark.

Reported private-company financials and secondary-market indications may be unaudited, incomplete, non-standard, or based on limited transaction activity. They should not be relied upon as fair value, executable pricing, or a basis for any investment decision.

Iceye offered €2.05 billion in cash to take Italian rocket maker Avio private

Iceye offered on Tuesday to pay €41 a share in cash for Avio, about €2.05 billion in all, according to the offer notice as reported by EconoTimes. That’s 21.3% above Avio’s closing price the day before. Iceye plans to delist Avio if the offer succeeds.

The direction runs opposite to an IPO, with a private company offering public shareholders cash for a buyout. Iceye was valued above €10 billion in its Series F in June, Tech Funding News reported.

The offer is conditioned on acceptances for at least 66.67% of Avio’s shares, a threshold Iceye can waive, AeroTime reported. Leonardo, the Italian aerospace and defense group, holds 18.04%, and the offer notice discloses no commitment from it to tender. Without Leonardo, the threshold works out to about 81.3% of the shares it doesn’t hold. That puts Leonardo’s decision near the center of the offer. Leonardo, Avio and the Italian government did express early support for the deal, Reuters reported, as cited by Breaking Defense.

Approvals in Europe and the US are also required, according to AeroTime. A full offer document follows once Italy’s market regulator approves it, Startup Researcher reported.

Reported private-company financials and secondary-market indications may be unaudited, incomplete, non-standard, or based on limited transaction activity. They should not be relied upon as fair value, executable pricing, or a basis for any investment decision.

Quick Takes

The following items reference financings, valuations, offerings, and transactions for market context only and are not recommendations or valuation opinions.

Apollo funds back Focus Financial. Apollo funds are putting about $2.5 billion into the wealth-management firm at roughly $21 billion including debt, Bloomberg reported, as cited by InvestmentNews. Neither the size of the investment nor the resulting valuation have been confirmed by Focus Financial.

Kalshi suspends some Trump mention markets. Kalshi paused some markets on what President Trump will say after a CFTC stay issued Nov. 13, and it has until Dec. 11 to respond, Cointelegraph reported.

Augment and/or its affiliates hold a position in Kalshi.

Astromech buys Form Bio in stock. The Colossal Biosciences spinoff is paying $230 million in stock for Form Bio, another Colossal spinoff, the companies said.

The Funding Lineup

The following financing rounds are included for market context only and are not recommendations or valuation opinions.

Isomorphic Labs: $5 billion Series C (Nov. 17) Greenoaks and Sequoia co-led the round, Alphabet invested again and Andreessen Horowitz joined, according to Fierce Biotech. No valuation was disclosed. The drug-discovery company raised $2.1 billion in May and plans to move its first drug programs toward clinical trials. Six months later, it raised more than twice as much, with no program yet in the clinic.

Genesis AI: $500 million Series A (Nov. 17) Khosla Ventures, Premji Invest and Eclipse co-led the round, TechCrunch reported. Axios reported the $3.5 billion post-money valuation and Nvidia’s participation. Genesis raised its seed round in July 2025 and is piloting its Eno humanoid robot with undisclosed customers. That makes Nvidia a participant in three deals in this issue, alongside Anthropic’s placement and Applied Compute’s round. Wednesday’s Deep Dive described how differently that role can work from one deal to the next.

Augment and/or its affiliates hold a position in Anthropic.

Payhawk: $280 million Series C at $2 billion (Nov. 18) Goldman Sachs led the round, with QED, Greenoaks and Lightspeed among the investors, Crowdfund Insider and Axios reported. The London-based spend management company was valued at $1 billion in a 2022 Series B extension, according to the company. The new valuation is twice that mark, four years later.

Model ML: $250 million Series B at $1.5 billion (Nov. 17) General Atlantic and QED Investors co-led the round, General Atlantic said. The London company builds what it calls “an AI platform for financial and professional services.” It raised a $75 million Series A led by FT Partners a year earlier. This round is more than three times that size.

Science Corporation: $400 million Series D (Nov. 17) Khosla Ventures and Y Combinator were among the backers. A person familiar with the deal told TechCrunch the round valued the company at $3.5 billion, more than twice the $1.5 billion post-money mark from its March Series C. Founder Max Hodak, a former Neuralink president, is scaling up its PRIMA retinal implant for vision loss.

General Flash: $128 million seed and Series A (Nov. 17) Lux Capital and Overmatch Ventures led the financing, Axios reported. The Cambridge, Mass., company has developed a process for producing critical metals. Founder Ric Fulop previously started A123 Systems and Desktop Metal. The company said it is scaling to commercial production for defense and commercial customers.

Reported private-company financials and secondary-market indications may be unaudited, incomplete, non-standard, or based on limited transaction activity. They should not be relied upon as fair value, executable pricing, or a basis for any investment decision.

Data Point of the Day

$550 million

Anthropic’s underwriting discount, the fee its banks keep from the IPO proceeds, according to the final prospectus. That works out to about 56 cents a share, or 0.68% of the price. It excludes the company’s other offering expenses. No discount is paid on the private placement or on any shares sold through the underwriters’ option.

Augment and/or its affiliates hold a position in Anthropic.

From the Manual

Concurrent private placement

A sale of shares to selected investors that runs alongside a public offering, outside the underwritten deal. Anthropic’s seven private placement buyers pay the IPO price for non-voting Class N shares. The underwriters’ lock-up doesn’t cover them, but the shares are restricted securities, so reselling them requires registration or an exemption.

Augment and/or its affiliates hold a position in Anthropic.

What We’re Watching

Anthropic’s first release dates and the underwriters’ option. Certain holders’ first lock-up window opens Dec. 15, and the underwriters can buy up to 147 million more shares within 30 days, according to the prospectus. The first would add to the shares that can trade, and an exercise of the option would add to the shares outstanding.

Augment and/or its affiliates hold a position in Anthropic.

Applied Compute’s closing. Palo Alto expects the deal to close in its fiscal third quarter of 2027, after regulatory clearance, according to its release. The closing terms would show what the adjustments do to the $4.5 billion headline.

Avio’s offer document. Iceye’s full offer document follows once Italy’s market regulator approves it, Startup Researcher reported. It would set out the offer’s timetable and conditions, including how the acceptance threshold applies.

Augment Markets Inc. is a technology company offering software and data services. Brokerage services are offered through Augment Capital LLC, an affiliated broker-dealer and member FINRA/SIPC. Investment advisory services are offered through Augment Advisors LLC, an SEC-registered investment adviser.

Important Disclosures: This material has been prepared for informational purposes only. None of the information provided represents a recommendation, an offer or the solicitation of an offer to buy or sell any security. The information provided does not constitute investment, legal, tax, or accounting advice. You should consult with qualified professionals before making any investment decisions. Investing in private securities involves substantial risk, including the potential loss of principal. Private securities are typically illiquid, have limited pricing transparency, and often require longer holding periods. These investments are available exclusively to qualified accredited investors and offer no guarantee of returns. An IPO or other liquidity event is not guaranteed. Additionally, past performance of private securities does not indicate or predict future results. Share price data are estimates only, based on proprietary data from Caplight and Augment Markets Inc. and its affiliates.

Alex O'Donnell

Learn more